Which of the following drugs does not inhibit bacterial protein synthesis?
Which type of vaccine is used for chicken pox?
Which antibiotic is Actinomycosis sensitive to?
Which of the following drugs is not used for prophylaxis against malaria?
Which of the following is not used as treatment for lymphatic filariasis -
In a child admitted with Haemophilus influenzae meningitis, cefotaxime was started instead of ampicillin. Which of the following is the likely reason for this?
Anaerobic bacteria are intrinsically resistant to which of the following antibiotics?
Which of the following antimalarials is a slow-acting schizonticide?
On chronic use, linezolid leads to which of the following?
What is the recommended duration of erythromycin for the treatment of diphtheria?
Explanation: ***Sulfonamides*** - Sulfonamides do **NOT** inhibit bacterial protein synthesis; instead, they inhibit **folic acid synthesis**. - They act as **competitive inhibitors** of dihydropteroate synthase, an enzyme involved in the synthesis of dihydrofolic acid. - Folic acid is essential for nucleotide synthesis and DNA replication, making sulfonamides bacteriostatic agents that work through a completely different mechanism than protein synthesis inhibitors. *Aminoglycosides* - Aminoglycosides bind to the **30S ribosomal subunit**, causing misreading of mRNA and premature termination of protein synthesis. - This leads to the production of **abnormal and non-functional proteins**, ultimately killing the bacterial cell. *Chloramphenicol* - Chloramphenicol binds to the **50S ribosomal subunit**, thereby inhibiting the peptidyl transferase enzyme. - This prevents the formation of **peptide bonds** between amino acids, effectively blocking protein elongation. *Clindamycin* - Clindamycin also binds to the **50S ribosomal subunit**, specifically at the P-site. - It interferes with the **translocation step** of protein synthesis, preventing ribosomal movement along the mRNA.
Explanation: ***Live vaccine*** - The chickenpox vaccine (Varicella vaccine) is a **live-attenuated vaccine**, meaning it contains a weakened form of the **Varicella-zoster virus** (Oka strain). - This weakened virus can still replicate in the body, stimulating a strong and long-lasting immune response similar to natural infection but without causing severe disease. *Killed vaccine* - **Killed (inactivated) vaccines** use viruses or bacteria that have been inactivated through heat or chemicals, making them unable to replicate. - While effective for some diseases (e.g., inactivated polio, influenza), they typically require **multiple doses** and might provide less durable immunity compared to live vaccines. *Conjugated vaccine* - **Conjugated vaccines** are designed to improve the immune response to polysaccharide antigens (e.g., bacterial capsules) by linking them to a carrier protein. - This technology is primarily used for **bacterial infections** like *Haemophilus influenzae* type b (Hib) or pneumococcal disease, not viral illnesses like chickenpox. *Toxoid vaccine* - **Toxoid vaccines** contain inactivated bacterial toxins (toxoids) rather than the whole organism. - Examples include **tetanus and diphtheria vaccines**, which protect against diseases caused by bacterial toxins, not viral infections like chickenpox.
Explanation: ***Penicillin*** - **Penicillin** is the **antibiotic of choice** for treating Actinomycosis due to the organism's high sensitivity. - Treatment typically involves a **long course** of high-dose penicillin for several months. *Streptomycin* - **Streptomycin** is an **aminoglycoside antibiotic** primarily used for **tuberculosis** and some gram-negative bacterial infections. - It is **not effective** against Actinomyces species. *Nystatin* - **Nystatin** is an **antifungal medication** used to treat **yeast infections**, particularly Candida. - It has **no antibacterial activity** and thus no role in treating Actinomycosis. *Doxycycline* - While **doxycycline** can be used as an **alternative** in patients allergic to penicillin, it is **not the primary choice**. - Its effectiveness is generally less pronounced than penicillin, and it's reserved for second-line treatment.
Explanation: Artesunate - **Artesunate** is a **fast-acting artemisinin derivative primarily used for treating acute malaria infections, especially severe or complicated cases**, and is not recommended for prophylaxis [4]. - Its short half-life and rapid clearance make it unsuitable for preventing malaria, as it would require frequent dosing, which is impractical for long-term prevention. *Doxycycline* - **Doxycycline** is an **antibiotic** that can be used for malaria prophylaxis, particularly in areas with **chloroquine-resistant P. falciparum** [1]. - It works by inhibiting protein synthesis in the parasite and must be taken daily, starting before travel and continuing for a period after returning [1]. *Chloroquine* - **Chloroquine** was historically a cornerstone for malaria prophylaxis due to its effectiveness and low cost, particularly in areas with **sensitive Plasmodium species.** [2] - However, widespread **chloroquine resistance**, especially in **P. falciparum**, has limited its current use for prophylaxis to specific regions where resistance is not prevalent [2]. *Mefloquine* - **Mefloquine** is an **antimalarial drug** commonly used for prophylaxis, especially in areas with **chloroquine-resistant P. falciparum** [2], [3]. - It is known for its convenience of once-weekly dosing but can have significant **neuropsychiatric side effects**, limiting its use in some individuals [3].
Explanation: ***Praziquantel*** - **Praziquantel** is primarily an **anthelmintic drug** effective against **schistosomiasis** and **tapeworm infections**. - It does not have a significant role in the treatment of **lymphatic filariasis**. *Ivermectin* - **Ivermectin** is one of the **mainstays** of treatment for **lymphatic filariasis**, particularly in combination therapies. - It works by paralyzing and killing **microfilariae**, reducing their numbers in the bloodstream. *DEC* - **Diethylcarbamazine (DEC)** is a **highly effective antifilarial drug** used to kill both **microfilariae** and **adult worms** in lymphatic filariasis. - It is often used in mass drug administration programs and for individual treatment. *Albendazole* - **Albendazole** is an **anthelmintic drug** often used in combination with **Ivermectin** or **DEC** for the treatment of **lymphatic filariasis**. - It helps to kill **microfilariae** and has some macrofilaricidal effects, reducing the viability of adult worms.
Explanation: ***H. influenzae strains known to produce Beta lactamase*** - Many *H. influenzae* strains, particularly in meningitis, produce **beta-lactamase enzymes** that inactivate ampicillin. - **Cefotaxime**, a third-generation cephalosporin, is **stable against beta-lactamases**, making it an effective empirical treatment. *Easier to give* - The route and ease of administration are generally **not the primary factors** in choosing between ampicillin and cefotaxime in a severe infection like meningitis. - Both medications can be administered intravenously, which is standard for meningitis treatment. *It is cheap* - While cost is a consideration in healthcare, **efficacy and clinical outcome** for a life-threatening condition like meningitis take precedence over cost. - Treatment choices are primarily driven by **antimicrobial susceptibility patterns** and patient safety. *H. influenzae strains known to have altered penicillin binding protein* - While **altered penicillin-binding proteins (PBPs)** can lead to resistance in some bacteria (e.g., *Streptococcus pneumoniae*), it is **not the predominant mechanism of resistance** to ampicillin in *H. influenzae*. - **Beta-lactamase production** is the much more common and significant reason for ampicillin resistance in *H. influenzae*.
Explanation: ***Aminoglycosides (e.g., gentamicin)*** - Anaerobic bacteria lack the **oxygen-dependent transport systems** necessary to take up aminoglycosides into the bacterial cell. - This results in **intrinsic resistance** because the drug cannot reach its intracellular ribosomal target. *Beta-lactams (e.g., penicillin)* - While some anaerobes (like certain *Bacteroides* species) can be resistant to specific beta-lactams due to **beta-lactamase production**, it's not an intrinsic resistance across all anaerobes to all beta-lactams. - Many anaerobes are **susceptible to penicillin**, especially those that do not produce beta-lactamase, or to beta-lactamase inhibitors combination drugs. *Chloramphenicol (broad-spectrum antibiotic)* - Chloramphenicol is effective against many anaerobic bacteria by inhibiting **protein synthesis**. - Anaerobes are generally **susceptible** to chloramphenicol, and it is not an antibiotic to which they are intrinsically resistant. *Metronidazole (used for anaerobic infections)* - Metronidazole is a **prodrug** that requires anaerobic conditions to become activated. - It is highly effective against most obligate anaerobes and is a common choice for treating **anaerobic infections**, indicating susceptibility, not intrinsic resistance.
Explanation: ***Pyrimethamine***- Pyrimethamine is a **folate antagonist** [1, 2] that acts as a **slow-acting schizonticide** [1, 3], primarily inhibiting dihydrofolate reductase in the parasite [1].- Due to its slow onset [1], it is typically used in combination with other faster-acting antimalarials, such as sulfadoxine, for treatment or prophylaxis [1].*Artemether*- Artemether is an **artemisinin derivative**, known for its **rapid action** and potent effect against all erythrocytic stages of *Plasmodium falciparum*.- It is a **fast-acting schizonticide** that causes widespread damage to parasite membranes and proteins.*Mefloquine*- Mefloquine is an antimalarial drug recognized for its **long half-life** and efficacy against multidrug-resistant *Plasmodium falciparum*.- While effective, it is considered of **intermediate speed** compared to the rapid action of artemisinins or the very slow action of drugs like pyrimethamine.*Quinine*- Quinine is a **fast-acting schizonticide** that is effective against the asexual erythrocytic forms of *Plasmodium* parasites.- Although potent, its use is limited by potential adverse effects such as **cinchonism** and a short half-life requiring frequent dosing.
Explanation: ***Thrombocytopenia*** - **Linezolid** is known to cause **myelosuppression**, particularly **thrombocytopenia**, with prolonged use (typically >2 weeks). - This adverse effect is usually **reversible** upon discontinuation of the drug. - This is the **most characteristic** and **dose-limiting** hematologic toxicity of chronic linezolid therapy. *Deranged LFT* - While **linezolid** can occasionally cause **elevated liver enzymes**, this is a **less common** adverse effect compared to myelosuppression. - **Thrombocytopenia** is far more characteristic of **chronic linezolid use** and is the primary concern requiring monitoring. - Hepatotoxicity with linezolid is typically mild and less dose-limiting than hematologic effects. *Nephrotoxicity* - **Linezolid** is generally considered to have a low risk of **nephrotoxicity** and does not typically cause significant kidney damage. - **Aminoglycosides** or **vancomycin** are examples of antibiotics more commonly associated with nephrotoxic effects. *Ototoxicity* - **Ototoxicity**, characterized by hearing loss or tinnitus, is not a common or recognized side effect of **linezolid** therapy. - This adverse effect is more frequently associated with drugs like **aminoglycosides** or high-dose **loop diuretics**.
Explanation: ***14 days*** - The recommended duration for **erythromycin** in treating diphtheria is **14 days** to ensure eradication of *Corynebacterium diphtheriae* and prevent toxin production. - This duration helps to eliminate the carrier state and reduce the risk of transmission to others. *3 days* - A 3-day course of antibiotics is **insufficient** for the complete eradication of *Corynebacterium diphtheriae* in diphtheria. - Such a short duration would likely lead to **treatment failure** and persistence of the infection. *7 days* - While 7 days is a common antibiotic duration for some infections, it is generally considered **too short** for diphtheria treatment. - A 7-day course may not fully eliminate the bacteria, potentially leading to **relapse** or a prolonged carrier state. *30 days* - A 30-day course of erythromycin for diphtheria is **unnecessarily long** and could increase the risk of side effects and antibiotic resistance. - The goal is eradication without excessive drug exposure, which 14 days achieves effectively.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free